VERONA PHARMA PLC - AM
74.73
20-May-25 15:45:00
15 minutes delayed
Stocks
+2.15
+2.96%
Today's range
72.15 - 75.47
ISIN
N/A
Source
NASDAQ
-
15 Aug 2022 15:05:00 By Nasdaq GlobeNewswire
-
Verona Pharma plc Announces Pricing of Upsized Underwritten Public Offering
10 Aug 2022 19:22:20 By Nasdaq GlobeNewswire
-
Verona Pharma plc Announces Proposed Underwritten Public Offering
09 Aug 2022 15:16:44 By Nasdaq GlobeNewswire
-
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
09 Aug 2022 02:01:03 By Nasdaq GlobeNewswire
-
Verona Pharma Announces Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-2 Trial for COPD
09 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
08 Aug 2022 15:30:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Report Second Quarter 2022 Financial Results and Provide Corporate Update
29 Jul 2022 01:00:00 By Nasdaq GlobeNewswire
-
09 Jun 2022 01:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Host KOL Event on June 16, 2022
06 Jun 2022 01:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Present at Jefferies Healthcare Conference
25 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
09 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma Announces May 2022 Investor Conference Participation
04 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update
03 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Report First Quarter 2022 Financial Results and Provide Corporate Update
19 Apr 2022 01:00:00 By Nasdaq GlobeNewswire
-
James Brady Joins Verona Pharma as Non-Executive Director
14 Mar 2022 02:00:00 By Nasdaq GlobeNewswire
-
03 Mar 2022 01:00:00 By Nasdaq GlobeNewswire
-
17 Feb 2022 01:00:00 By Nasdaq GlobeNewswire
-
24 Jan 2022 01:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma Completes Enrollment in ENHANCE-1 48-week Subset
05 Jan 2022 01:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Present at H.C. Wainwright BioConnect Virtual Conference
04 Jan 2022 01:00:00 By Nasdaq GlobeNewswire